ResearcherRoswell Park Comprehensive Cancer CenterNo recent work listed
Anurag K. Singh
Matched on ORCID iD 0000-0002-6703-5115; OpenAlex author ID A5100320563.
Their work
- Papers
- 6 (first author 0, last author 6)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 1
2018: 1 paper · 2019: 3 papers · 2020: none · 2021: none · 2022: 2 papers
Papers 6
- Adjuvant chemotherapy versus observation following neoadjuvant therapy and surgery for resectable stage I-II pancreatic cancer. Last author DOI 10.1017/s1460396921000194↗
- Association of survival with stereotactic body radiation therapy following induction chemotherapy for unresected locally advanced pancreatic cancer. Last author DOI 10.1017/s1460396921000212↗
- Association of Timing of Adjuvant Therapy With Survival in Patients With Resected Stage I to II Pancreatic Cancer. Last author DOI 10.1001/jamanetworkopen.2019.9126↗
- Adjuvant chemotherapy followed by concurrent chemoradiation is associated with improved survival for resected stage I-II pancreatic cancer. Last author DOI 10.1002/cam4.1967↗
- Duration of chemotherapy prior to chemoradiation affects survival outcomes for resected stage I-II or unresected stage III pancreatic cancer. Last author DOI 10.1002/cam4.2326↗
- Dose escalation of radiation therapy with or without induction chemotherapy for unresectable locally advanced pancreatic cancer. Last author DOI 10.1186/s13014-018-1158-z↗
Closest collaborators
The 1 strongest of 1 ranked by shared papers, trials and grants, with recent and small-team work weighing most.
- Sung Jun Ma · 6 shared papers, 2018–2022
- Paper Adjuvant chemotherapy versus observation following neoadjuvant therapy and surgery for resectable stage I-II pancreatic… DOI 10.1017/s1460396921000194↗
- Paper Association of survival with stereotactic body radiation therapy following induction chemotherapy for unresected locall… DOI 10.1017/s1460396921000212↗
- Paper Duration of chemotherapy prior to chemoradiation affects survival outcomes for resected stage I-II or unresected stage … DOI 10.1002/cam4.2326↗
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.